From professional translators, enterprises, web pages and freely available translation repositories.
laropiprant:
laropiprant:
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
nicotinsyre og laropiprant.
what pelzont contains • the active substances are nicotinic acid and laropiprant.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
andre lægemidlers indvirkning på laropiprant
effects of other medicinal products on laropiprant
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
2 gange ved flergangsdosering af laropiprant.
however, the plasma concentration of a metabolite of midazolam, 1'-hydroxymidazolam, was increased approximately 2-fold with multiple doses of laropiprant.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
aktive stoffer: nicotinsyre og laropiprant.
the active substances are nicotinic acid and laropiprant.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
dyreforsøg har vist udskillelse af laropiprant i mælken.
animal studies have shown excretion of laropiprant in milk.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
det er ukendt, om laropiprant udskilles i modermælk.
it is unknown whether laropiprant is excreted in human breast milk.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
laropiprant forventes ikke at hæmme produktionen af prostaglandiner.
laropiprant is not expected to inhibit the production of prostaglandins.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
laropiprant laropiprants indvirkning på andre lægemidler midazolam:
laropiprant effects of laropiprant on other medicinal products midazolam:
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
laropiprant: dosisjustering er ikke nødvendig på basis af køn.
laropiprant: no dose adjustment is necessary based on gender.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
andre lægemidlers indvirkning på laropiprant cyp3a4- hæmmer:
effects of other medicinal products on laropiprant cyp3a4 inhibitor:
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
laropiprant blokerer de receptorer, som pgd2 normalt binder sig til.
laropiprant blocks the receptors to which pgd2 normally attaches.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
derfor er laropiprant ikke en inducer eller hæmmer af cyp3a4.
therefore, laropiprant is not an inducer or inhibitor of cyp3a4.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
laropiprant der foreligger ingen data for anvendelsen af laropiprant til gravide.
laropiprant there are no data from the use of laropiprant in pregnant women.
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
dyreforsøg har vist føtal udviklingstoksicitet ved høje doser laropiprant (se pkt.
studies in animals have shown foetal developmental toxicity at high doses of laropiprant (see section 5.3).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
laropiprant var ikke mutagent eller klastogent i en række af genetiske toksilogiundersøgelser.
laropiprant was not mutagenic or clastogenic in a series of genetic toxicology studies.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
de to aktive stoffer i pelzont, nikotinsyre og laropiprant, har forskellige virkemåder.
the two active substances in pelzont, nicotinic acid and laropiprant, have different modes of action.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
pelzont 1.000 mg/20 mg tabletter med modificeret udløsning nicotinsyre/laropiprant
pelzont 1,000 mg/20 mg modified-release tablets nicotinic acid/laropiprant
Last Update: 2017-04-26
Usage Frequency: 6
Quality:
når patienten tager tabletten, frigives laropiprant først til blodbanen og blokerer pgd2-receptorerne.
when the patient takes the tablet, laropiprant is released first into the bloodstream and blocks the pgd2 receptors.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
laropiprant elimineres primært via acylglucuronidering efterfulgt af glucuronidudskillelse i fæces (via galden) og urin.
laropiprant is eliminated primarily via acyl glucuronidation, followed by excretion of the glucuronide in faeces (via bile) and urine.
Last Update: 2017-04-26
Usage Frequency: 1
Quality: